SEATTLE, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology ... President of Reagent and Platform Development. Both executives join the company’s product development team.

Improving the flow, handling and interpretation of information is a tremendous accelerant for biotech product development,” said Dr. Michael Fero, Chief Executive Officer, TeselaGen. Terms of ...

SEATTLE--(BUSINESS WIRE)--Lumen Bioscience, a synthetic biotechnology company developing a novel bio-based product development platform, announced today it has raised $13 million of new capital ...